The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer.

Ioannis KyvernitakisK KostevP Hadji

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2018)

Compared to healthy controls, premenopausal women with breast cancer treated with tamoxifen showed an increased risk of fracture, while postmenopausal women on tamoxifen did not show any risk reduction.

Keyphrases

postmenopausal women
bone mineral density
breast cancer cells
estrogen receptor
positive breast cancer
early stage
breast cancer risk
body composition